Adis Journal Podcasts

In this podcast, Aman Chauhan from the Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, USA, Deborah Robertson, patient advocate, Lombard, IL, USA, and Susan Meckler-Plummer from Minkahz NETs Mission, Atlanta, GA, USA discuss the diagnosis and treatment of extrapulmonary neuroendocrine carcinoma, highlighting challenges and unmet needs from the perspectives of a medical oncologist, patient, caregiver, and patient advocacy group founder.
This podcast is published open access in Targeted Oncology and is fully citeable. You can access the original published podcast article through the Targeted Oncology website and by using this link: https://link.springer.com/article/10.1007/s11523-026-01262-9. All conflicts...

Dengue Vodcast: Insights from Recent Infectious Disease Congresses

This podcast is published open access in Infectious Diseases and Therapy, and is fully citeable. You can access the original published podcast article through the Infectious Diseases and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40121-026-01428-y. All conflicts of interest can be found online. This podcast is intended for medical professionals.

Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and...

In this podcast, Thanyanan Reungwetwattana from the Division of Medical Oncology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, Kristin A. Higgins from the Department of Radiation Oncology, City of Hope Cancer Center Atlanta, Atlanta, GA, USA, Ignacio Casarini from the Servicio Oncología, Hospital Bernardo Houssay, Mar del Plata, Buenos Aires, Argentina, and Suresh S. Ramalingam from the Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA discuss considerations surrounding the implementation of the LAURA (NCT03521154) regimen (osimertinib after chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer) in clinical...

In this podcast, Shailender Bhatia from the Division of Hematology and Oncology, Department of Medicine, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA, Sandra D’Angelo from the Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA, and Paul Nghiem from the Department of Dermatology, University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA summarize key studies of ICIs in advanced MCC, including clinical trials and real-world studies, and discuss clinical evidence related to practical considerations, such as elective discontinuation of ICI treatment, and treatment...